small number of Black patients, a lack of data regarding biomarkers of alcohol consumption, genetic polymorphisms as a determinant of therapeutic response
Here are some essential questions to ask your doctor so you can make an informed decision: Am I a good candidate for GLP-1 therapy based on my health conditions
These effects appear to be more pronounced in aged than in younger subjects (n = 21, age 4875) (Mahdi et al., 2019), and does not depend on efficacy of blood glucose-lowering therapy in T2D patients (n = 16, average age 64) (Mahdi et al., 2018)
Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and, at higher doses (as Wegovy), for weight management in adults with obesity
After initially having a rather negative experience with Metformin, I made the decision to give it a try
If you have any concerns or need guidance during your treatment, dont hesitate to reach out to your Centra Internal Medicine care team
